Onderneming Immunovia AB London S.E.
Aandelen
0G8X
SE0006091997
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,4 SEK | -96,26% | -.--% | -22,82% |
29/04 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 | |
29/04 | Immunovia benoemt Lisa Ford tot klinisch laboratoriumdirecteur | CI |
Vakgebied
Aantal werknemers: 11
Verkoop per activiteit
SEK in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Non-invasive Blood Tests
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +35,66% |
Verkoop per regio
SEK in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Sweden
59,1
%
| 1 | 59,2 % | 1 | 59,1 % | +35,40% |
United States
40,9
%
| 0 | 0,0 % | 0 | 40,9 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 01-04-22 | |
Karl Stone
COO | Chief Operating Officer | 61 | 01-03-23 |
Chief Tech/Sci/R&D Officer | - | 01-02-23 | |
Linda Mellby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas C. King
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-01-17 |
Philipp Mathieu
BRD | Director/Board Member | 46 | 20-01-22 |
Tobias Bülow
IRC | Investor Relations Contact | - | 15-01-22 |
Cindy Callahan
SAM | Sales & Marketing | - | - |
Jon Hager
SAM | Sales & Marketing | - | 05-12-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 70 | 09-12-16 | |
Peter Andersen
CHM | Chairman | 67 | 01-01-20 |
Michael Löfman
BRD | Director/Board Member | - | 22-05-23 |
Martin Møller
BRD | Director/Board Member | 49 | 01-01-21 |
Eric Krafft
BRD | Director/Board Member | 49 | 01-04-22 |
Philipp Mathieu
BRD | Director/Board Member | 46 | 20-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 45 287 498 | 34 016 137 ( 75,11 %) | 0 | 75,11 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-42,86% | 2,85 mld. | |
+20,51% | 1,94 mld. | |
-1,13% | 1,68 mld. | |
+27,00% | 1,26 mld. | |
-14,07% | 1,03 mld. | |
-20,60% | 938 mln. | |
+0,88% | 783 mln. | |
-24,34% | 628 mln. | |
+8,73% | 535 mln. |
- Beurs
- Aandelen
- Koers IMMNOV
- Koers 0G8X
- Onderneming Immunovia AB